Given the variability in visual interpretation of MCP hyperintensities and the HCB sign among the three reviewers seen in the current study, the MCP sT1w/T2w ratio appears to be a feasible, reliable, and clinically valuable imaging biomarker for differentiating MSA-C from SCA3 or SCA6. The gene discussed is CACNA1A; the disease is multiple system atrophy, cerebellar type.